BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2020.
World J Hepatol. Nov 27, 2020; 12(11): 1076-1088
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1076
Figure 4
Figure 4 Linear regression model of hepatitis B surface antigen levels according to treatment group. NA: Nucleos(t)ids analogue; Peg-IFN: Pegylated interferon; LR: Linear regression.


Write to the Help Desk